Publicly traded employer-focused fertility and household constructing firm Progyny introduced it had acquired Berlin-based fertility advantages platform Apryl, thereby increasing its international attain.
The New York-based firm gives advantages packages specializing in household constructing, fertility and girls’s reproductive well being, together with IVF, adoption, IUI and surrogacy.
Apryl, which additionally focuses on the employer advantages market, permits firms to customise their choices to produce particular companies to their workers. The platform gives steerage, fertility planning companies, reproductive expertise, and adoption and surrogacy companies.
The corporate says that it additionally helps workers navigate native laws and necessities inside completely different nations, and that it has a database of clinics globally, together with their distinctive knowledge factors.
“This acquisition is thrilling as a result of it furthers our mission to extend entry to fertility and household constructing care around the globe. We are actually in a position to work with international employers to offer household constructing advantages in over 100 nations, supporting sufferers in over 225 languages,” Pete Anevski, CEO of Progyny, advised MobiHealthNews in an e-mail.
THE LARGER TREND
Progyny, which went public in 2019 underneath the ticker image PGNY, noticed its inventory value rise 0.31% right this moment to $25.94 per share, under this yr’s excessive of $40.78 in February.
In Could, the corporate reported its first-quarter 2024 earnings, noting income of $278.1 million in comparison with $258.4 million in Q1 2023, a 7.6% improve.
It reported an 8% improve in income from its fertility-benefit companies from $157.1 million within the first quarter of final yr to $169.8 million in Q1 of this yr.
Its pharmacy profit companies first-quarter income elevated 7% this yr in comparison with final yr, from $101.2 million in 2023 to $108.3 million in 2024.
The corporate reported a gross revenue of $62.4 million within the first quarter of the yr in comparison with $58.6 million final yr and web earnings of $16.9 million in Q1 2024 in comparison with $17.7 million in the identical interval the earlier yr.
Adjusted EBITDA was $50.3 million within the first quarter of 2024 in comparison with $46.4 million in the identical interval final yr.
